25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

82P (Pacira BioSciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Pacira BioSciences Inc together

I guess you are interested in Pacira BioSciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Pacira BioSciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Pacira BioSciences Inc’s Price Targets

I'm going to help you getting a better view of Pacira BioSciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pacira BioSciences Inc

I send you an email if I find something interesting about Pacira BioSciences Inc.

1. Quick Overview

1.1. Quick analysis of Pacira BioSciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Pacira BioSciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€15.51
Expected worth in 1 year
€13.77
How sure are you?
71.4%

+ What do you gain per year?

Total Gains per Share
€-1.74
Return On Investment
-8.4%

For what price can you sell your share?

Current Price per Share
€20.60
Expected price per share
€17.50 - €25.80
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pacira BioSciences Inc (5 min.)




Live pricePrice per Share (EOD)
€20.60
Intrinsic Value Per Share
€37.00 - €43.31
Total Value Per Share
€52.50 - €58.82

2.2. Growth of Pacira BioSciences Inc (5 min.)




Is Pacira BioSciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$778.3m$819.3m$5.4m0.7%

How much money is Pacira BioSciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$24.8m$10.4m-$35.3m-142.1%
Net Profit Margin-15.1%5.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Pacira BioSciences Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pacira BioSciences Inc?

Welcome investor! Pacira BioSciences Inc's management wants to use your money to grow the business. In return you get a share of Pacira BioSciences Inc.

First you should know what it really means to hold a share of Pacira BioSciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Pacira BioSciences Inc is €20.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pacira BioSciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pacira BioSciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €15.51. Based on the TTM, the Book Value Change Per Share is €-0.43 per quarter. Based on the YOY, the Book Value Change Per Share is €0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pacira BioSciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps0.351.7%-0.54-2.6%0.221.1%-0.04-0.2%-0.04-0.2%
Usd Book Value Change Per Share0.592.9%-0.47-2.3%0.462.2%1.205.8%1.205.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.592.9%-0.47-2.3%0.462.2%1.205.8%1.205.8%
Usd Price Per Share20.08-22.69-35.55-40.75-40.75-
Price to Earnings Ratio14.47-16.78-10.52--59.79--59.79-
Price-to-Total Gains Ratio34.06--38.75--20.81-50.49-50.49-
Price to Book Ratio1.19-1.26-2.02-2.41-2.41-
Price-to-Total Gains Ratio34.06--38.75--20.81-50.49-50.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share22.3613
Number of shares44
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.471.20
Usd Total Gains Per Share-0.471.20
Gains per Quarter (44 shares)-20.7652.90
Gains per Year (44 shares)-83.05211.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-83-930212202
20-166-1760423414
30-249-2590635626
40-332-3420846838
50-415-425010581050
60-498-508012701262
70-581-591014811474
80-664-674016931686
90-747-757019041898
100-830-840021162110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%9.05.00.064.3%9.05.00.064.3%9.05.00.064.3%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%10.04.00.071.4%10.04.00.071.4%10.04.00.071.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%10.04.00.071.4%10.04.00.071.4%10.04.00.071.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pacira BioSciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.543-0.435+180%0.425+28%1.108-51%1.108-51%
Book Value Per Share--15.50616.425-6%16.293-5%15.823-2%15.823-2%
Current Ratio--2.4044.322-44%4.441-46%3.852-38%3.852-38%
Debt To Asset Ratio--0.4990.477+5%0.469+6%0.513-3%0.513-3%
Debt To Equity Ratio--0.9960.918+8%0.887+12%1.095-9%1.095-9%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--141366412.400274869008.950-49%849334436.600-83%931368581.814-85%931368581.814-85%
Eps--0.320-0.497+256%0.207+54%-0.041+113%-0.041+113%
Ev To Ebitda Ratio--infnannan%infnan%nannan%nannan%
Ev To Sales Ratio--0.2050.429-52%1.373-85%1.574-87%1.574-87%
Free Cash Flow Per Share--0.6180.890-31%0.692-11%0.708-13%0.708-13%
Free Cash Flow To Equity Per Share--0.5790.977-41%-0.223+139%0.427+36%0.427+36%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--43.311--------
Intrinsic Value_10Y_min--36.997--------
Intrinsic Value_1Y_max--3.099--------
Intrinsic Value_1Y_min--3.043--------
Intrinsic Value_3Y_max--10.257--------
Intrinsic Value_3Y_min--9.773--------
Intrinsic Value_5Y_max--18.555--------
Intrinsic Value_5Y_min--17.141--------
Market Cap--855451174.000967145512.050-12%1516502021.600-44%1715372686.614-50%1715372686.614-50%
Net Profit Margin--0.086-0.151+277%0.058+47%-0.012+114%-0.012+114%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.0551.106-5%1.147-8%1.126-6%1.126-6%
Pb Ratio1.329+10%1.1931.256-5%2.021-41%2.411-51%2.411-51%
Pe Ratio16.116+10%14.47316.778-14%10.519+38%-59.789+513%-59.789+513%
Price Per Share20.600+10%18.50020.900-11%32.750-44%37.536-51%37.536-51%
Price To Free Cash Flow Ratio8.335+10%7.4866.045+24%16.229-54%17.845-58%17.845-58%
Price To Total Gains Ratio37.928+10%34.062-38.754+214%-20.813+161%50.488-33%50.488-33%
Quick Ratio--1.0361.869-45%2.336-56%1.951-47%1.951-47%
Return On Assets--0.010-0.017+262%0.007+54%-0.001+114%-0.001+114%
Return On Equity--0.021-0.035+269%0.012+71%-0.004+118%-0.004+118%
Total Gains Per Share--0.543-0.435+180%0.425+28%1.108-51%1.108-51%
Usd Book Value--778318889.785824811900.881-6%819393603.533-5%788357871.456-1%788357871.456-1%
Usd Book Value Change Per Share--0.590-0.472+180%0.461+28%1.202-51%1.202-51%
Usd Book Value Per Share--16.83217.830-6%17.686-5%17.176-2%17.176-2%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--153453240.660298370309.215-49%921952530.929-83%1011000595.559-85%1011000595.559-85%
Usd Eps--0.347-0.540+256%0.225+54%-0.045+113%-0.045+113%
Usd Free Cash Flow--31012840.07644686578.659-31%34870695.787-11%35334321.304-12%35334321.304-12%
Usd Free Cash Flow Per Share--0.6710.966-31%0.752-11%0.769-13%0.769-13%
Usd Free Cash Flow To Equity Per Share--0.6281.060-41%-0.242+139%0.463+36%0.463+36%
Usd Market Cap--928592249.3771049836453.330-12%1646162944.447-44%1862037051.320-50%1862037051.320-50%
Usd Price Per Share22.361+10%20.08222.687-11%35.550-44%40.745-51%40.745-51%
Usd Profit--16040400.067-24889069.114+255%10488357.721+53%-2083207.799+113%-2083207.799+113%
Usd Revenue--187245996.738175234945.968+7%168738188.956+11%166399704.990+13%166399704.990+13%
Usd Total Gains Per Share--0.590-0.472+180%0.461+28%1.202-51%1.202-51%
 EOD+2 -4MRQTTM+16 -19YOY+18 -175Y+15 -2010Y+15 -20

3.3 Fundamental Score

Let's check the fundamental score of Pacira BioSciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.116
Price to Book Ratio (EOD)Between0-11.329
Net Profit Margin (MRQ)Greater than00.086
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.036
Current Ratio (MRQ)Greater than12.404
Debt to Asset Ratio (MRQ)Less than10.499
Debt to Equity Ratio (MRQ)Less than10.996
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.010
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Pacira BioSciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.635
Ma 20Greater thanMa 5022.680
Ma 50Greater thanMa 10022.512
Ma 100Greater thanMa 20019.567
OpenGreater thanClose20.400
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Pacira BioSciences Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Pacira BioSciences Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • A Net Profit Margin of 8.6%Β means thatΒ €0.09 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pacira BioSciences Inc:

  • The MRQ is 8.6%. The company is making a profit. +1
  • The TTM is -15.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ8.6%TTM-15.1%+23.7%
TTM-15.1%YOY5.8%-21.0%
TTM-15.1%5Y-1.2%-13.9%
5Y-1.2%10Y-1.2%0.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Pacira BioSciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • 1.0% Return on Assets means thatΒ Pacira BioSciences Inc generatedΒ €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pacira BioSciences Inc:

  • The MRQ is 1.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is -1.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.0%TTM-1.7%+2.7%
TTM-1.7%YOY0.7%-2.3%
TTM-1.7%5Y-0.1%-1.5%
5Y-0.1%10Y-0.1%0.0%
4.3.1.3. Return on Equity

Shows how efficient Pacira BioSciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • 2.1% Return on Equity means Pacira BioSciences Inc generated €0.02Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pacira BioSciences Inc:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -3.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.1%TTM-3.5%+5.5%
TTM-3.5%YOY1.2%-4.7%
TTM-3.5%5Y-0.4%-3.1%
5Y-0.4%10Y-0.4%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pacira BioSciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Pacira BioSciences Inc is operatingΒ .

  • Measures how much profit Pacira BioSciences Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pacira BioSciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Pacira BioSciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ  industry mean).
  • An Operation Ratio of 1.06 means that the operating costs are €1.06 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Pacira BioSciences Inc:

  • The MRQ is 1.055. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.106. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.055TTM1.106-0.051
TTM1.106YOY1.147-0.041
TTM1.1065Y1.126-0.020
5Y1.12610Y1.1260.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pacira BioSciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pacira BioSciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ  industry mean).
  • A Current Ratio of 2.40Β means the company has €2.40 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Pacira BioSciences Inc:

  • The MRQ is 2.404. The company is able to pay all its short-term debts. +1
  • The TTM is 4.322. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.404TTM4.322-1.918
TTM4.322YOY4.441-0.119
TTM4.3225Y3.852+0.471
5Y3.85210Y3.8520.000
4.4.3.2. Quick Ratio

Measures if Pacira BioSciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • A Quick Ratio of 1.04Β means the company can pay off €1.04 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pacira BioSciences Inc:

  • The MRQ is 1.036. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.869. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.036TTM1.869-0.832
TTM1.869YOY2.336-0.468
TTM1.8695Y1.951-0.083
5Y1.95110Y1.9510.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pacira BioSciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Pacira BioSciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Pacira BioSciences Inc to industry mean.
  • A Debt to Asset Ratio of 0.50Β means that Pacira BioSciences Inc assets areΒ financed with 49.9% credit (debt) and the remaining percentage (100% - 49.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Pacira BioSciences Inc:

  • The MRQ is 0.499. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.477. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.499TTM0.477+0.022
TTM0.477YOY0.469+0.008
TTM0.4775Y0.513-0.036
5Y0.51310Y0.5130.000
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Pacira BioSciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • A Debt to Equity ratio of 99.6% means that company has €1.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pacira BioSciences Inc:

  • The MRQ is 0.996. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.918. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.996TTM0.918+0.078
TTM0.918YOY0.887+0.032
TTM0.9185Y1.095-0.176
5Y1.09510Y1.0950.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Pacira BioSciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Pacira BioSciences Inc to theΒ  industry mean.
  • A PE ratio of 14.47 means the investor is paying €14.47Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pacira BioSciences Inc:

  • The EOD is 16.116. Based on the earnings, the company is fair priced.
  • The MRQ is 14.473. Based on the earnings, the company is underpriced. +1
  • The TTM is 16.778. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.116MRQ14.473+1.643
MRQ14.473TTM16.778-2.305
TTM16.778YOY10.519+6.259
TTM16.7785Y-59.789+76.567
5Y-59.78910Y-59.7890.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pacira BioSciences Inc:

  • The EOD is 8.335. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.486. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.045. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.335MRQ7.486+0.850
MRQ7.486TTM6.045+1.440
TTM6.045YOY16.229-10.183
TTM6.0455Y17.845-11.799
5Y17.84510Y17.8450.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Pacira BioSciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to industry mean).
  • A PB ratio of 1.19 means the investor is paying €1.19Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Pacira BioSciences Inc:

  • The EOD is 1.329. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.193. Based on the equity, the company is underpriced. +1
  • The TTM is 1.256. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.329MRQ1.193+0.135
MRQ1.193TTM1.256-0.063
TTM1.256YOY2.021-0.766
TTM1.2565Y2.411-1.156
5Y2.41110Y2.4110.000
4.6.2. Total Gains per Share

2.4. Latest News of Pacira BioSciences Inc

Does Pacira BioSciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Pacira BioSciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-03-02
18:27
Is Pacira BioSciences, Inc. (PCRX) the Best Small Cap Pharma Stock to Buy Now?Read
2025-03-02
13:41
Earnings Update: Here's Why Analysts Just Lifted Their Pacira BioSciences, Inc. (NASDAQ:PCRX) Price Target To US$31.71Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,553,516
Total Liabilities775,168
Total Stockholder Equity778,348
 As reported
Total Liabilities 775,168
Total Stockholder Equity+ 778,348
Total Assets = 1,553,516

Assets

Total Assets1,553,516
Total Current Assets745,130
Long-term Assets808,386
Total Current Assets
Cash And Cash Equivalents 276,774
Short-term Investments 207,841
Net Receivables 113,304
Inventory 125,282
Other Current Assets 21,929
Total Current Assets  (as reported)745,130
Total Current Assets  (calculated)745,130
+/-0
Long-term Assets
Property Plant Equipment 216,391
Intangible Assets 425,970
Long-term Assets Other 35,649
Long-term Assets  (as reported)808,386
Long-term Assets  (calculated)678,010
+/- 130,376

Liabilities & Shareholders' Equity

Total Current Liabilities309,920
Long-term Liabilities465,248
Total Stockholder Equity778,348
Total Current Liabilities
Short Long Term Debt 201,776
Accounts payable 19,133
Total Current Liabilities  (as reported)309,920
Total Current Liabilities  (calculated)220,909
+/- 89,011
Long-term Liabilities
Long term Debt 383,545
Capital Lease Obligations Min Short Term Debt53,532
Long-term Liabilities Other 37,058
Long-term Liabilities  (as reported)465,248
Long-term Liabilities  (calculated)474,135
+/- 8,887
Total Stockholder Equity
Total Stockholder Equity (as reported)778,348
Total Stockholder Equity (calculated)0
+/- 778,348
Other
Capital Stock47
Common Stock Shares Outstanding 46,241
Net Debt 308,547
Net Invested Capital 1,363,669
Net Working Capital 435,210
Property Plant and Equipment Gross 349,320



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
1,356,002
2,075,353
1,891,476
1,733,988
1,734,365
1,681,200
1,523,418
1,542,381
1,534,462
1,574,386
1,583,321
1,646,820
1,521,691
1,553,516
1,553,5161,521,6911,646,8201,583,3211,574,3861,534,4621,542,3811,523,4181,681,2001,734,3651,733,9881,891,4762,075,3531,356,002
   > Total Current Assets 
822,352
866,048
667,018
526,210
533,411
498,334
376,114
429,324
447,255
509,994
543,113
632,214
689,969
745,130
745,130689,969632,214543,113509,994447,255429,324376,114498,334533,411526,210667,018866,048822,352
       Cash And Cash Equivalents 
134,036
585,578
226,751
122,061
109,424
104,139
35,545
86,810
99,119
153,298
184,052
247,053
245,965
276,774
276,774245,965247,053184,052153,29899,11986,81035,545104,139109,424122,061226,751585,578134,036
       Short-term Investments 
559,822
70,831
225,443
194,332
219,301
184,512
138,454
133,956
136,069
125,283
141,838
157,173
207,845
207,841
207,841207,845157,173141,838125,283136,069133,956138,454184,512219,301194,332225,44370,831559,822
       Net Receivables 
49,975
96,318
92,103
91,105
93,471
98,397
93,205
99,079
96,956
105,556
101,639
104,779
100,653
113,304
113,304100,653104,779101,639105,55696,95699,07993,20598,39793,47191,10592,10396,31849,975
       Inventory 
67,209
98,550
103,662
100,588
96,799
96,063
92,977
92,130
96,520
104,353
96,782
103,438
111,865
125,282
125,282111,865103,43896,782104,35396,52092,13092,97796,06396,799100,588103,66298,55067,209
   > Long-term Assets 
533,650
1,209,305
1,224,458
1,207,778
1,200,954
1,182,866
1,147,304
1,113,057
1,087,207
1,064,392
1,040,208
1,014,606
831,722
808,386
808,386831,7221,014,6061,040,2081,064,3921,087,2071,113,0571,147,3041,182,8661,200,9541,207,7781,224,4581,209,305533,650
       Property Plant Equipment 
0
0
0
0
263,308
254,389
249,701
246,147
239,177
234,947
230,430
225,114
220,682
216,391
216,391220,682225,114230,430234,947239,177246,147249,701254,389263,3080000
       Goodwill 
99,547
145,175
145,722
146,132
157,361
163,243
163,243
163,243
163,243
163,243
163,243
163,243
0
0
00163,243163,243163,243163,243163,243163,243163,243157,361146,132145,722145,17599,547
       Long Term Investments 
21,192
21,987
35,770
35,812
43,752
37,209
8,281
0
0
2,410
36,542
36,499
36,726
0
036,72636,49936,5422,410008,28137,20943,75235,81235,77021,98721,192
       Intangible Assets 
90,621
623,968
609,646
595,324
581,002
540,546
526,224
511,902
497,580
483,258
468,936
454,614
440,292
425,970
425,970440,292454,614468,936483,258497,580511,902526,224540,546581,002595,324609,646623,96890,621
> Total Liabilities 
637,400
1,344,945
1,181,900
977,352
964,242
906,190
755,377
734,406
702,911
704,256
691,159
767,542
772,108
775,168
775,168772,108767,542691,159704,256702,911734,406755,377906,190964,242977,3521,181,9001,344,945637,400
   > Total Current Liabilities 
225,788
521,118
305,073
133,179
131,526
147,774
98,698
108,912
93,661
97,383
93,444
92,690
306,401
309,920
309,920306,40192,69093,44497,38393,661108,91298,698147,774131,526133,179305,073521,118225,788
       Short Long Term Debt 
155,751
374,700
193,680
33,776
33,872
33,648
10,853
19,504
8,641
8,641
8,641
0
201,466
201,776
201,776201,46608,6418,6418,64119,50410,85333,64833,87233,776193,680374,700155,751
       Accounts payable 
7,895
10,543
14,843
13,983
12,933
15,220
17,261
24,206
16,511
15,698
8,982
18,730
19,367
19,133
19,13319,36718,7308,98215,69816,51124,20617,26115,22012,93313,98314,84310,5437,895
       Other Current Liabilities 
5,070
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000005,070
   > Long-term Liabilities 
411,612
823,827
876,827
844,173
832,716
758,416
656,679
625,494
609,250
606,873
597,715
674,852
465,707
465,248
465,248465,707674,852597,715606,873609,250625,494656,679758,416832,716844,173876,827823,827411,612
       Long term Debt 
326,146
674,530
729,743
721,878
713,999
655,823
542,918
532,183
515,941
513,796
511,687
589,300
385,891
383,545
383,545385,891589,300511,687513,796515,941532,183542,918655,823713,999721,878729,743674,530326,146
       Capital Lease Obligations Min Short Term Debt
72,663
79,618
77,728
75,709
73,765
73,923
71,393
69,027
65,714
63,607
61,449
59,295
57,066
53,532
53,53257,06659,29561,44963,60765,71469,02771,39373,92373,76575,70977,72879,61872,663
       Long-term Liabilities Other 
18,682
67,445
67,249
54,720
53,316
37,791
51,319
33,265
36,220
38,271
33,582
35,406
31,941
37,058
37,05831,94135,40633,58238,27136,22033,26551,31937,79153,31654,72067,24967,44518,682
> Total Stockholder Equity
718,602
730,408
709,576
756,636
770,123
775,010
768,041
807,975
831,551
870,130
892,162
879,278
749,583
778,348
778,348749,583879,278892,162870,130831,551807,975768,041775,010770,123756,636709,576730,408718,602
   Common Stock00000000000000
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue700,966
Cost of Revenue-170,428
Gross Profit530,538530,538
 
Operating Income (+$)
Gross Profit530,538
Operating Expense-603,392
Operating Income97,574-72,854
 
Operating Expense (+$)
Research Development81,577
Selling General Administrative294,099
Selling And Marketing Expenses0
Operating Expense603,392375,676
 
Net Interest Income (+$)
Interest Income19,689
Interest Expense-13,439
Other Finance Cost-3,130
Net Interest Income3,120
 
Pretax Income (+$)
Operating Income97,574
Net Interest Income3,120
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-63,106261,374
EBIT - interestExpense = -13,439
-99,560
-86,121
Interest Expense13,439
Earnings Before Interest and Taxes (EBIT)0-49,667
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-63,106
Tax Provision-36,454
Net Income From Continuing Ops-99,560-99,560
Net Income-99,560
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-163,800-3,120
 

Technical Analysis of Pacira BioSciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pacira BioSciences Inc. The general trend of Pacira BioSciences Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pacira BioSciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Pacira BioSciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pacira BioSciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 25.20 < 25.80 < 25.80.

The bearish price targets are: 19.10 > 17.50 > 17.50.

Tweet this
Pacira BioSciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pacira BioSciences Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pacira BioSciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pacira BioSciences Inc. The current macd is -0.81171528.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pacira BioSciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pacira BioSciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pacira BioSciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pacira BioSciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartPacira BioSciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pacira BioSciences Inc. The current adx is 28.20.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pacira BioSciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Pacira BioSciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pacira BioSciences Inc. The current sar is 22.40.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pacira BioSciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pacira BioSciences Inc. The current rsi is 37.63. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Pacira BioSciences Inc Daily Relative Strength Index (RSI) ChartPacira BioSciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pacira BioSciences Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pacira BioSciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Pacira BioSciences Inc Daily Stochastic Oscillator ChartPacira BioSciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pacira BioSciences Inc. The current cci is -89.8002103.

Pacira BioSciences Inc Daily Commodity Channel Index (CCI) ChartPacira BioSciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pacira BioSciences Inc. The current cmo is -30.28604298.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pacira BioSciences Inc Daily Chande Momentum Oscillator (CMO) ChartPacira BioSciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pacira BioSciences Inc. The current willr is -85.18518519.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pacira BioSciences Inc Daily Williams %R ChartPacira BioSciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Pacira BioSciences Inc.

Pacira BioSciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pacira BioSciences Inc. The current atr is 0.69954201.

Pacira BioSciences Inc Daily Average True Range (ATR) ChartPacira BioSciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pacira BioSciences Inc. The current obv is 25.00.

Pacira BioSciences Inc Daily On-Balance Volume (OBV) ChartPacira BioSciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pacira BioSciences Inc. The current mfi is 40.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pacira BioSciences Inc Daily Money Flow Index (MFI) ChartPacira BioSciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pacira BioSciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Pacira BioSciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pacira BioSciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.635
Ma 20Greater thanMa 5022.680
Ma 50Greater thanMa 10022.512
Ma 100Greater thanMa 20019.567
OpenGreater thanClose20.400
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pacira BioSciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Pacira BioSciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pacira BioSciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pacira BioSciences Inc

I send you an email if I find something interesting about Pacira BioSciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pacira BioSciences Inc.

Receive notifications about Pacira BioSciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.